XSS in Hcl Myxalytics
CVE-2025-52653
HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.
Vulnerability class: XSS (Cross-Site Scripting)
Published · last modified .
CVSS v3 metric
CVSS v3 base score 7.6 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:H/I:L/A:H.
EPSS exploit prediction
EPSS: 0.003 (15.9th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 16th percentile — 15.9% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.002 · newest: 0.003 · change: +0.000
Affected products
- Hcl Myxalytics — versions 6.6
- Hcltech Dryice Myxalytics — versions 6.6
Weakness classification (CWE)
Public proof-of-concept exploits
References
- support.hcl-software.com/csm (Vendor Advisory)
Frequently asked questions
- What is CVE-2025-52653?
- CVE-2025-52653 is a high-severity vulnerability in Hcl Myxalytics, classified under Cross-site Scripting. CVSS score: 7.6/10. Published 2025-10-03.
- How severe is CVE-2025-52653?
- High severity. CVSS v3 base score is 7.6 out of 10.
- Is CVE-2025-52653 known to be exploited?
- 1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.